消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2020 JGES/JGCA指南：早期胃癌内镜黏膜下剥离术内镜下黏膜切除术（第2版）

2020-10-26 日本消化器内视镜学会 Dig Endosc . 2020 Oct 26.

胃癌内镜黏膜下剥离术

2020年10月，日本消化器内视镜学会(JGES)联合日本胃癌学会(JGCA)共同发布了早期胃癌内镜黏膜下剥离术内镜下黏膜切除术第2版，该指南是对2015年发布的第一版指南的更新。指南主要内容涉及早期

中文标题：

2020 JGES/JGCA指南：早期胃癌内镜黏膜下剥离术内镜下黏膜切除术（第2版）

英文标题：

Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition)

发布机构：

日本消化器内视镜学会

发布日期：

2020-10-26

简要介绍：

2020年10月，日本消化器内视镜学会(JGES)联合日本胃癌学会(JGCA)共同发布了早期胃癌内镜黏膜下剥离术内镜下黏膜切除术第2版，该指南是对2015年发布的第一版指南的更新。指南主要内容涉及早期胃癌内镜黏膜下剥离术/内镜下黏膜切除术的适应证，术前诊断，操作技术，可治愈性评估，并发症，术后长期监测和组织病理学检查。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 JGES_JGCA指南：早期胃癌内镜黏膜下剥离术内镜下黏膜切除术（第2版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6fde81c002002ebc, title=2020 JGES/JGCA指南：早期胃癌内镜黏膜下剥离术内镜下黏膜切除术（第2版）, enTitle=Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition), guiderFrom=Dig Endosc . 2020 Oct 26., authorId=0, author=, summary=2020年10月，日本消化器内视镜学会(JGES)联合日本胃癌学会(JGCA)共同发布了早期胃癌内镜黏膜下剥离术内镜下黏膜切除术第2版，该指南是对2015年发布的第一版指南的更新。指南主要内容涉及早期, cover=https://img.medsci.cn/20201031/1604075530985_2020535.jpg, journalId=0, articlesId=null, associationId=1094, associationName=日本消化器内视镜学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Oct 26 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年10月，日本消化器内视镜学会(JGES)联合日本胃癌学会(JGCA)共同发布了早期胃癌内镜黏膜下剥离术内镜下黏膜切除术第2版，该指南是对2015年发布的第一版指南的更新。指南主要内容涉及早期胃癌内镜黏膜下剥离术/内镜下黏膜切除术的适应证，术前诊断，操作技术，可治愈性评估，并发症，术后长期监测和组织病理学检查。</p> </div> </div> </div>, tagList=[TagDto(tagId=438, tagName=胃癌), TagDto(tagId=49110, tagName=内镜黏膜下剥离术)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=438, guiderKeyword=胃癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4515, appHits=371, showAppHits=0, pcHits=1249, showPcHits=4144, likes=3, shares=36, comments=26, approvalStatus=1, publishedTime=Sat Oct 31 00:51:53 CST 2020, publishedTimeString=2020-10-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 31 00:32:19 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:24:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 JGES_JGCA指南：早期胃癌内镜黏膜下剥离术内镜下黏膜切除术（第2版）.pdf)])
2020 JGES_JGCA指南：早期胃癌内镜黏膜下剥离术内镜下黏膜切除术（第2版）.pdf
下载请点击：
评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1062126, encodeId=b18b1062126d0, content=写的很详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5f85528337, createdName=江洲一叶, createdTime=Tue Oct 19 23:51:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059044, encodeId=9d2e10590445e, content=新人积分不够啊，556, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69805629838, createdName=ms7000000484457472, createdTime=Sat Oct 09 20:20:33 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003446, encodeId=4ad71003446b2, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a645400263, createdName=ms6000001049645463, createdTime=Wed Jul 28 21:44:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003038, encodeId=2428100303844, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210727/7f63519050864cdd83ae356ba8030379/27a6dfafd5d141d9acce4fd410492eb4.jpg, createdBy=d7895557885, createdName=ms4000000239681306, createdTime=Tue Jul 27 16:12:40 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977695, encodeId=ecc59e769538, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf5534504, createdName=ms9000001016613565, createdTime=Mon Jun 28 20:24:29 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-10-19 江洲一叶

    写的很详细

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1062126, encodeId=b18b1062126d0, content=写的很详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5f85528337, createdName=江洲一叶, createdTime=Tue Oct 19 23:51:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059044, encodeId=9d2e10590445e, content=新人积分不够啊，556, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69805629838, createdName=ms7000000484457472, createdTime=Sat Oct 09 20:20:33 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003446, encodeId=4ad71003446b2, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a645400263, createdName=ms6000001049645463, createdTime=Wed Jul 28 21:44:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003038, encodeId=2428100303844, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210727/7f63519050864cdd83ae356ba8030379/27a6dfafd5d141d9acce4fd410492eb4.jpg, createdBy=d7895557885, createdName=ms4000000239681306, createdTime=Tue Jul 27 16:12:40 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977695, encodeId=ecc59e769538, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf5534504, createdName=ms9000001016613565, createdTime=Mon Jun 28 20:24:29 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-10-09 ms7000000484457472

    新人积分不够啊，556

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1062126, encodeId=b18b1062126d0, content=写的很详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5f85528337, createdName=江洲一叶, createdTime=Tue Oct 19 23:51:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059044, encodeId=9d2e10590445e, content=新人积分不够啊，556, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69805629838, createdName=ms7000000484457472, createdTime=Sat Oct 09 20:20:33 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003446, encodeId=4ad71003446b2, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a645400263, createdName=ms6000001049645463, createdTime=Wed Jul 28 21:44:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003038, encodeId=2428100303844, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210727/7f63519050864cdd83ae356ba8030379/27a6dfafd5d141d9acce4fd410492eb4.jpg, createdBy=d7895557885, createdName=ms4000000239681306, createdTime=Tue Jul 27 16:12:40 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977695, encodeId=ecc59e769538, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf5534504, createdName=ms9000001016613565, createdTime=Mon Jun 28 20:24:29 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-07-28 ms6000001049645463

    太有用了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1062126, encodeId=b18b1062126d0, content=写的很详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5f85528337, createdName=江洲一叶, createdTime=Tue Oct 19 23:51:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059044, encodeId=9d2e10590445e, content=新人积分不够啊，556, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69805629838, createdName=ms7000000484457472, createdTime=Sat Oct 09 20:20:33 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003446, encodeId=4ad71003446b2, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a645400263, createdName=ms6000001049645463, createdTime=Wed Jul 28 21:44:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003038, encodeId=2428100303844, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210727/7f63519050864cdd83ae356ba8030379/27a6dfafd5d141d9acce4fd410492eb4.jpg, createdBy=d7895557885, createdName=ms4000000239681306, createdTime=Tue Jul 27 16:12:40 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977695, encodeId=ecc59e769538, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf5534504, createdName=ms9000001016613565, createdTime=Mon Jun 28 20:24:29 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-07-27 ms4000000239681306

    写得好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1062126, encodeId=b18b1062126d0, content=写的很详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5f85528337, createdName=江洲一叶, createdTime=Tue Oct 19 23:51:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059044, encodeId=9d2e10590445e, content=新人积分不够啊，556, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69805629838, createdName=ms7000000484457472, createdTime=Sat Oct 09 20:20:33 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003446, encodeId=4ad71003446b2, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a645400263, createdName=ms6000001049645463, createdTime=Wed Jul 28 21:44:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003038, encodeId=2428100303844, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210727/7f63519050864cdd83ae356ba8030379/27a6dfafd5d141d9acce4fd410492eb4.jpg, createdBy=d7895557885, createdName=ms4000000239681306, createdTime=Tue Jul 27 16:12:40 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977695, encodeId=ecc59e769538, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf5534504, createdName=ms9000001016613565, createdTime=Mon Jun 28 20:24:29 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-06-28 ms9000001016613565

    值得学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

巴西胃癌诊治共识 2020

巴西胃癌协会 · 2020-08-02

胃癌诊治难点中国专家共识（2020 版）

中国抗癌协会胃癌专业委员会 · 2020-08-01

新型冠状病毒肺炎疫情期间胃癌全程管理专家共识

暂未更新 · 2020-03-30

2019 国际共识：胃癌经自然腔道取标本手术（NOSES）

国外普通外科相关专家组（统称） · 2020-01-24

中国幽门螺杆菌根除与胃癌防控的专家共识意见（2019年,上海）

中华医学会消化病学分会(CSGE,Chinese Society Of Gastroenterology) · 2019-05-29

拓展阅读

2010 NACB医学实践指南：肝癌、膀胱癌、子宫颈癌、胃癌肿瘤标志物的应用

美国临床生化科学院(NACB,The National Academy of Clinical Biochemistry) · 2010-01-01

ESMO指南：胃癌诊断、治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-01-01

卡培他滨治疗进展期胃癌

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2010-07-24

2011 卫生部《胃癌诊疗规范》

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-02-25

2010年 日本胃癌治疗指南（第三版）（英文）

日本胃癌学会(JGCA,Japanese Gastric Cancer Association) · 2011-05-14

日本胃癌分期处理规约（第三版）

日本胃癌学会(JGCA,Japanese Gastric Cancer Association) · 2011-05-15